TERN
Terns Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$37.77
+2.43 (+6.88%)
Performance
1D
—
1W
+2.58%
1M
+10.73%
3M
+83.53%
6M
+481.97%
1Y
+746.86%
YTD
-5.83%
Open$35.45
Previous Close$35.34
Day High$38.03
Day Low$35.45
52W High$48.26
52W Low$1.87
Volume1.76M
Avg Volume2.28M
Market Cap4.02B
P/E Ratio—
EPS$-1.03
SectorPharmaceuticals
Volume Analysis
0.77x average volume
Technical Indicators
SMA 50
$37.02
Above
SMA 200
$14.79
Above
RSI (14)
54.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
-1.6% upside
Current
$37.77
$37.77
Target
$37.17
$37.17
$32.00
$37.17 avg
$56.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 649.21M | 641.61M | 607.21M |
| Net Income | 208.45M | 199.92M | 172.59M |
| Profit Margin | 32.1% | 31.2% | 28.4% |
| EBITDA | 253.94M | 217.05M | 208.00M |
| Free Cash Flow | 152.21M | 227.98M | 177.76M |
| Rev Growth | -4.4% | +22.1% | +20.7% |
| Debt/Equity | 0.17 | 0.24 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |